SHAYNA PARSONS: Open Payments
NPI 1609466424 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 49 payments from 18 companies in 2025. Trend: 2023 $279 · 2024 $1,062 · 2025 $1,429
Food & beverage: $1,159Education: $270
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 2 | $304 |
| Astellas Pharma US Inc | 4 | $218 |
| Incyte Corporation | 6 | $176 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Janssen Biotech, Inc. | 7 | $130 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Genentech USA, Inc. | 4 | $75 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Celgene Corporation | 3 | $49 |
| SOBI, INC | 2 | $40 |
Products named: RYTELO, LYNPARZA, JAKAFI, KEYTRUDA, DARZALEX, Tecentriq, OJJAARA, Vonjo.
Industry payments across MD — which companies pay providers there.
